Director NAGAMURA Fumitaka
Advanced Clinical Research Center (ACRC) collaborates with basic research groups in IMSUT to translate the research outcomes into medical practice at IMSUT Hospital. The missions of ACRC are to perform clinical sciences targeting malignancies (mainly hematological malignancies and gastrointestinal malignancies), infectious diseases (such as COVID-19) and immunological diseases. ACRC also aims to translate its own research outcomes into early-phase clinical trials and to undertake the feed-back experiments from its own clinical experiences. For this purpose, ACRC is developing novel therapeutics utilizing various resources. Each division of ACRC performs peculiar medical research based on the concept of bench to bed, and proposes the ideas elucidating clinical problems from bed to bench. Therefore, each division has a close contact with basic scientists inside and outside IMSUT.
Currently, ACRC consists of 11 divisions: Division of Hematopoietic Disease Control, Division of Infectious Diseases, Division of Clinical Genome Research, Division of Frontier Surgery, Division of Innovative Cancer Therapy, Division of Advanced Medicine Promotion, Division of Advanced Genome Medicine Division of Advanced Gastroenterology and Endoscopy, Division of Anesthesia and Surgical Homeostasis, Division of Hematology and Tumor Biology, and Division of Bioethics and Medical Law. Many of the staff members are physicians who support the clinical operations of the IMSUT Hospital while also engaging in new medical developments.
Advanced Clinical Research Center
-
Division of Infectious Diseases
-
Division of Clinical Genome Research
-
Division of Innovative Cancer Therapy
-
Division of Advanced Medicine Promotion
-
Division of Advanced Genome Medicine
-
Division of Frontier Surgery
-
Division of Hematopoietic Disease Control
-
Division of Advanced Gastroenterology and Endoscopy
-
Division of Anesthesia and Surgical Homeostasis
-
Division of Hematology and Tumor Biology
-
Division of Bioethics and Medical Law